BioCrossroads invests in LumenRECON to aid stent deployment
BioCrossroads’ Indiana Seed Fund invested $250,000 in Indianapolis biomedical engineer FlowCo’s LumenRECON, a catheter-based device that uses electricity to size the cross-section of a blood vessel.
According to FlowCo, LumenRECON has four electrical wires that are mounted on the exterior of any standard catheter and inserted into the blood vessel. Electrical currents are sent to the electrodes, which gives the cardiologist a digital output of the measurement for the blood vessel's cross-sectional area in real-time.
Ghassan Kassab, inventor of LumenRECON and president of FlowCo, said the funding will enable the company to make a human-use prototype for clinical trials scheduled to take place by next summer, for which it is currently preparing regulatory documents.
According to FlowCo, LumenRECON has four electrical wires that are mounted on the exterior of any standard catheter and inserted into the blood vessel. Electrical currents are sent to the electrodes, which gives the cardiologist a digital output of the measurement for the blood vessel's cross-sectional area in real-time.
Ghassan Kassab, inventor of LumenRECON and president of FlowCo, said the funding will enable the company to make a human-use prototype for clinical trials scheduled to take place by next summer, for which it is currently preparing regulatory documents.